Hamon Annaïg, Masson Christel, Bitard Juliette, Gieser Linn, Roger Jérôme E, Perron Muriel
Paris-Saclay Institute of Neuroscience, CNRS, Univ Paris-Sud, Université Paris-Saclay, Orsay, France 2Centre d'Etude et de Recherche Thérapeutique en Ophtalmologie, Retina France, Orsay, France.
Neurobiology-Neurodegeneration & Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):1941-1953. doi: 10.1167/iovs.16-21366.
During retinal degeneration, Müller glia cells respond to photoreceptor loss by undergoing reactive gliosis, with both detrimental and beneficial effects. Increasing our knowledge of the complex molecular response of Müller cells to retinal degeneration is thus essential for the development of new therapeutic strategies. The purpose of this work was to identify new factors involved in Müller cell response to photoreceptor cell death.
Whole transcriptome sequencing was performed from wild-type and degenerating rd10 mouse retinas at P30. The changes in mRNA abundance for several differentially expressed genes were assessed by quantitative RT-PCR (RT-qPCR). Protein expression level and retinal cellular localization were determined by western blot and immunohistochemistry, respectively.
Pathway-level analysis from whole transcriptomic data revealed the Hippo/YAP pathway as one of the main signaling pathways altered in response to photoreceptor degeneration in rd10 retinas. We found that downstream effectors of this pathway, YAP and TEAD1, are specifically expressed in Müller cells and that their expression, at both the mRNA and protein levels, is increased in rd10 reactive Müller glia after the onset of photoreceptor degeneration. The expression of Ctgf and Cyr61, two target genes of the transcriptional YAP/TEAD complex, is also upregulated following photoreceptor loss.
This work reveals for the first time that YAP and TEAD1, key downstream effectors of the Hippo pathway, are specifically expressed in Müller cells. We also uncovered a deregulation of the expression and activity of Hippo/YAP pathway components in reactive Müller cells under pathologic conditions.
在视网膜变性过程中,Müller神经胶质细胞通过发生反应性胶质增生对光感受器丧失作出反应,这既有有害影响也有有益影响。因此,增进我们对Müller细胞对视网膜变性复杂分子反应的了解对于开发新的治疗策略至关重要。这项工作的目的是确定参与Müller细胞对光感受器细胞死亡反应的新因素。
在P30对野生型和退化的rd10小鼠视网膜进行全转录组测序。通过定量逆转录聚合酶链反应(RT-qPCR)评估几个差异表达基因的mRNA丰度变化。分别通过蛋白质印迹和免疫组织化学确定蛋白质表达水平和视网膜细胞定位。
对全转录组数据的通路水平分析显示,Hippo/YAP通路是rd10视网膜中因光感受器退化而改变的主要信号通路之一。我们发现该通路的下游效应物YAP和TEAD1在Müller细胞中特异性表达,并且在光感受器退化开始后,它们在rd10反应性Müller神经胶质细胞中的mRNA和蛋白质水平表达均增加。转录YAP/TEAD复合物的两个靶基因Ctgf和Cyr61的表达在光感受器丧失后也上调。
这项工作首次揭示YAP和TEAD1这两个Hippo通路的关键下游效应物在Müller细胞中特异性表达。我们还发现在病理条件下,反应性Müller细胞中Hippo/YAP通路成分的表达和活性失调。